Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

Launched by FRENCH AFRICA PEDIATRIC ONCOLOGY GROUP · Jun 2, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on improving the treatment of children diagnosed with Hodgkin lymphoma, a type of cancer that affects the lymphatic system. The researchers aim to create a clear and effective way to stage the disease using various types of information, such as clinical exams and imaging tests. They also want to develop treatment recommendations that are tailored to whether radiation therapy is available at the hospitals involved in the study.

To participate in this trial, children must be under 18 years old at the time of their Hodgkin lymphoma diagnosis and must have "classical" Hodgkin's disease, as classified by the World Health Organization. They should not have a history of blood cancers or immune system disorders. If eligible, participants can expect to receive care based on the latest research, and their treatment plans may differ depending on the resources available at their treatment center. This study is currently recruiting participants of all genders, and it aims to find the best ways to help young patients with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • under 18 years of age at diagnosis
• • suffering from "classical" Hodgkin's disease according to the WHO classification.
• • with no history of hematological malignancies or constitutional or acquired immune deficiencies
• Exclusion Criteria:
• • Over 18 years of age at diagnosis
• • A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies